Russia and Nicaragua are developing a vaccine against dengue fever that requires high technology

The clinical trial phase will begin in the near future.

'At the initiative of the (Nicaraguan) president, Daniel Ortega, a vaccine against dengue has been developed, which will enter the clinical trial phase in the near future'

The director of the Russian Federal Medical and Biological Agency, Veronika Skvortsova, said that the dengue vaccine will soon enter “the clinical trial phase.”

According to the Pan American Health Organization (PAHO), close to 500 million people in the Americas are at risk of contracting dengue